[go: up one dir, main page]

NL175059B - Bereiding van bloeddrukverlagende stoffen en van preparaten die ze bevatten. - Google Patents

Bereiding van bloeddrukverlagende stoffen en van preparaten die ze bevatten.

Info

Publication number
NL175059B
NL175059B NLAANVRAGE7501877,A NL7501877A NL175059B NL 175059 B NL175059 B NL 175059B NL 7501877 A NL7501877 A NL 7501877A NL 175059 B NL175059 B NL 175059B
Authority
NL
Netherlands
Prior art keywords
blood
preparation
preparations containing
pressure substances
substances
Prior art date
Application number
NLAANVRAGE7501877,A
Other languages
English (en)
Dutch (nl)
Other versions
NL7501877A (nl
Original Assignee
Boehringer Mannheim Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim Gmbh filed Critical Boehringer Mannheim Gmbh
Publication of NL7501877A publication Critical patent/NL7501877A/xx
Publication of NL175059B publication Critical patent/NL175059B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NLAANVRAGE7501877,A 1974-02-23 1975-02-18 Bereiding van bloeddrukverlagende stoffen en van preparaten die ze bevatten. NL175059B (nl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2408804A DE2408804C2 (de) 1974-02-23 1974-02-23 1-(2-Methoxyphenyl)-4-[3-(naphth-1-yl-oxy)-2-hydroxy-propyl]-piperazin, dessen Salze, Verfahren zu ihrer Herstellung sowie Arzneimittel, die diese Verbindungen enthalten

Publications (2)

Publication Number Publication Date
NL7501877A NL7501877A (nl) 1975-08-26
NL175059B true NL175059B (nl) 1984-04-16

Family

ID=5908286

Family Applications (2)

Application Number Title Priority Date Filing Date
NLAANVRAGE7501877,A NL175059C (nl) 1974-02-23 Bereiding van bloeddrukverlagende stoffen en van preparaten die ze bevatten.
NLAANVRAGE7501877,A NL175059B (nl) 1974-02-23 1975-02-18 Bereiding van bloeddrukverlagende stoffen en van preparaten die ze bevatten.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
NLAANVRAGE7501877,A NL175059C (nl) 1974-02-23 Bereiding van bloeddrukverlagende stoffen en van preparaten die ze bevatten.

Country Status (20)

Country Link
US (1) US3997666A (el)
JP (1) JPS6029712B2 (el)
AR (1) AR206339A1 (el)
AT (1) AT340937B (el)
BE (1) BE825755A (el)
CA (1) CA1039282A (el)
CH (2) CH612958A5 (el)
DE (1) DE2408804C2 (el)
DK (1) DK135124C (el)
ES (1) ES434829A1 (el)
FI (1) FI59248C (el)
FR (1) FR2261770B1 (el)
GB (1) GB1445548A (el)
IE (1) IE40678B1 (el)
NL (2) NL175059B (el)
PL (1) PL92131B1 (el)
SE (1) SE405601B (el)
SU (2) SU549085A3 (el)
YU (2) YU37156B (el)
ZA (1) ZA751031B (el)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2387971A1 (fr) * 1977-04-19 1978-11-17 Delalande Sa Nouvelles trimethoxy cinnamoyles piperazines, leur procede de preparation et leur application en therapeutique
EP0269383A3 (en) * 1986-11-21 1990-05-02 A.H. Robins Company, Incorporated 1-Aryloxy-4-[(4-aryl)-1-piperazinyl]-2-butanols useful as antiallergy agents
US4882330A (en) * 1986-11-21 1989-11-21 A. H. Robins Company, Incorporated 1-aryloxy-4-[((4-aryl)-1-piperazinyl]-2-butanols useful as antiallergy agents
DE3918543A1 (de) * 1989-06-07 1990-12-13 Boehringer Mannheim Gmbh Verwendung von naftopidil zur therapie der dysurie bei benigner prostata-hypertrophie
DE3918542A1 (de) * 1989-06-07 1990-12-13 Boehringer Mannheim Gmbh Hydroxylierte 1-phenyl-4-(3-(napthth-1-yl-oxy)-2-hydroxy -propyl)-piperazine, verfahren zu ihrer herstellung sowie arzneimittel, die diese verbindungen enthalten
US20020143007A1 (en) * 1996-02-02 2002-10-03 Garvey David S. Nitrosated and nitrosylated alpha-adrenergic receptor antagonists, compositions and methods of use
US20050065161A1 (en) * 1996-02-02 2005-03-24 Nitromed, Inc. Nitrosated and nitrosylated alpha-adrenergic receptor antagonist compounds, compositions and their uses
US5932538A (en) * 1996-02-02 1999-08-03 Nitromed, Inc. Nitrosated and nitrosylated α-adrenergic receptor antagonist compounds, compositions and their uses
CA2278660A1 (en) 1997-01-30 1998-08-06 Kazumi Ogata Hydroquinone derivatives
KR100648869B1 (ko) 1998-09-30 2007-02-28 다케다 야쿠힌 고교 가부시키가이샤 방광 배출력 개선제
US20020065286A1 (en) * 2000-08-21 2002-05-30 Davies Michael John Treatment of wounds
US20020091129A1 (en) * 2000-11-20 2002-07-11 Mitradev Boolell Treatment of premature ejaculation
US20030229001A1 (en) * 2002-01-31 2003-12-11 Pfizer Inc. Treatment of male sexual dysfunction
WO2004017964A1 (en) 2002-08-19 2004-03-04 Pfizer Products Inc. Combination therapy for hyperproliferative diseases
GB0219961D0 (en) 2002-08-28 2002-10-02 Pfizer Ltd Oxytocin inhibitors
US7323462B2 (en) * 2002-12-10 2008-01-29 Pfizer Inc. Morpholine dopamine agonists
SI1572173T1 (sl) 2002-12-13 2010-08-31 Warner Lambert Co Alfa-2-delta ligand za zdravljenje simptomov spodnjega dela sečil
CA2451267A1 (en) * 2002-12-13 2004-06-13 Warner-Lambert Company Llc Pharmaceutical uses for alpha2delta ligands
PA8597401A1 (es) * 2003-03-14 2005-05-24 Pfizer Derivados del acido 3-(1-[3-(1,3-benzotiazol-6-il) propilcarbamoil] cicloalquil) propanoico como inhibidores de nep
US20040220186A1 (en) * 2003-04-30 2004-11-04 Pfizer Inc. PDE9 inhibitors for treating type 2 diabetes,metabolic syndrome, and cardiovascular disease
AU2004242777B2 (en) 2003-05-30 2011-05-12 Ranbaxy Laboratories Limited Substituted pyrrole derivatives and their use as HMG-Co inhibitors
US20050065158A1 (en) * 2003-07-16 2005-03-24 Pfizer Inc. Treatment of sexual dysfunction
US7291640B2 (en) * 2003-09-22 2007-11-06 Pfizer Inc. Substituted triazole derivatives as oxytocin antagonists
EP1863795B1 (en) 2005-03-21 2008-10-29 Pfizer Limited Substituted triazole derivatives as oxytocin antagonists
CA2618103A1 (en) * 2005-08-10 2007-02-15 Pfizer Limited Substituted triazole derivatives as oxytocin antagonists
GT200600381A (es) 2005-08-25 2007-03-28 Compuestos organicos
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
KR101329112B1 (ko) 2005-11-08 2013-11-14 랜박시 래보러터리스 리미티드 (3ｒ,5ｒ)-7-〔2-(4-플루오로페닐)-5-이소프로필-3-페닐-4-〔(4-히드록시 메틸 페닐 아미노)카르보닐〕-피롤-1-일〕-3,5-디히드록시 헵탄산 헤미 칼슘염의 제조 방법
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
US8383660B2 (en) 2006-03-10 2013-02-26 Pfizer Inc. Dibenzyl amine compounds and derivatives
US7919506B2 (en) 2006-03-10 2011-04-05 Pfizer Inc. Dibenzyl amine compounds and derivatives
WO2008050732A1 (fr) 2006-10-23 2008-05-02 Takeda Pharmaceutical Company Limited Dérivé de l'iminopyridine et son utilisation
CN101663262B (zh) 2006-12-01 2014-03-26 百时美施贵宝公司 用于治疗动脉粥样硬化和心血管疾病的作为cetp抑制剂的n-(3-苄基)-2,2-(二苯基)-丙-1胺衍生物
US20110039892A1 (en) * 2008-04-23 2011-02-17 Takeda Pharmaceutical Company Limited Iminopyridine derivative and use thereof
US8481569B2 (en) * 2008-04-23 2013-07-09 Takeda Pharmaceutical Company Limited Iminopyridine derivatives and use thereof
CN101671317B (zh) * 2009-10-09 2011-04-27 蚌埠丰原涂山制药有限公司 一种萘哌地尔的制备方法
CN101747293B (zh) * 2009-12-29 2011-12-07 蚌埠丰原涂山制药有限公司 萘哌地尔的制备方法
JP5807423B2 (ja) * 2011-07-21 2015-11-10 大日本印刷株式会社 ナフトピジルの製造方法
CN102816136A (zh) * 2012-09-18 2012-12-12 通化吉通药业有限公司 萘哌地尔制备方法
JP2016516804A (ja) 2013-04-17 2016-06-09 ファイザー・インク 心血管疾患を治療するためのｎ−ピペリジン−３−イルベンズアミド誘導体
US9272980B2 (en) 2014-06-06 2016-03-01 Ktn Biotec, Inc. Anticancer agent
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
LT3911648T (lt) 2019-01-18 2025-01-10 Astrazeneca Ab 6'-[[(1s,3s)-3-[[5-(difluormetoksi)-2-pirimidinil]amino]ciklopentil]amino][1(2h),3'-bipiridin]-2-onas kaip pcsk9 inhibitorius ir jo naudojimo būdai

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA967965A (en) * 1968-12-24 1975-05-20 Hoffmann-La Roche Limited Aromatic ethers and process for the manufacture thereof
GB1317479A (en) * 1970-11-10 1973-05-16 Pfizer Ltd 1-2-hydroxy-3-phenoxy or phenylthiopropyl-4-phenyl-piperazine derivatives
DE2235597A1 (de) * 1972-07-20 1974-01-31 Boehringer Mannheim Gmbh 1-eckige klammer auf 3-(5,6,7,8tetrahydronaphth-1-yl-oxy) -propyl eckige klammer zu -piperazin-derivate und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
FI59248C (fi) 1981-07-10
JPS6029712B2 (ja) 1985-07-12
YU38275A (en) 1983-04-27
FR2261770A1 (el) 1975-09-19
DE2408804A1 (de) 1975-09-04
NL175059C (nl)
FI750449A (el) 1975-08-24
SE405601B (sv) 1978-12-18
DE2408804C2 (de) 1983-09-22
CA1039282A (en) 1978-09-26
DK58175A (el) 1975-10-20
IE40678B1 (en) 1979-08-01
SU549085A3 (ru) 1977-02-28
ZA751031B (en) 1976-02-25
PL92131B1 (el) 1977-03-31
AR206339A1 (es) 1976-07-15
YU37156B (en) 1984-08-31
ES434829A1 (es) 1976-12-01
JPS50121286A (el) 1975-09-23
SE7501911L (el) 1975-08-25
YU37157B (en) 1984-08-31
DK135124C (da) 1977-08-15
NL7501877A (nl) 1975-08-26
GB1445548A (en) 1976-08-11
FR2261770B1 (el) 1978-08-04
SU561514A3 (ru) 1977-06-05
IE40678L (en) 1975-08-23
AU7826875A (en) 1976-08-19
BE825755A (fr) 1975-08-20
FI59248B (fi) 1981-03-31
YU104481A (en) 1983-04-27
US3997666A (en) 1976-12-14
ATA132375A (de) 1977-05-15
CH612958A5 (el) 1979-08-31
CH609342A5 (el) 1979-02-28
DK135124B (da) 1977-03-07
AT340937B (de) 1978-01-10

Similar Documents

Publication Publication Date Title
NL175059B (nl) Bereiding van bloeddrukverlagende stoffen en van preparaten die ze bevatten.
NL7409404A (nl) Fungiciden en preparaten die deze fungiciden bevatten.
NL7413085A (nl) Farmaceutisch en/of cosmetisch preparaat uitwendig gebruik.
NL174349B (nl) Werkwijze voor de bereiding van derivaten van 2-amino-1-pyridylethanol en werkwijze voor de bereiding van preparaten die ze bevatten.
NL7510535A (nl) Werkwijze ter bereiding van nieuwe arylpiperi- dinen, alsmede werkwijze ter bereiding van farmaceutische preparaten.
NL7512848A (nl) Werkwijze voor de bereiding van contraceptieve stoffen en preparaten.
NL7501032A (nl) Werkwijze ter bereiding van anti-tuberkelmid- delen, alsmede farmaceutische preparaten die deze middelen bevatten.
ZA751102B (en) Pharmaceutical preparations
NL7410371A (nl) Farmaceutische of cosmetische preparaten.
NL7514255A (nl) Werkwijze voor de bereiding van piperidylindolen en farmaceutische preparaten die ze bevatten.
NL7611085A (nl) Werkwijze voor de bereiding van neuroleptisch werkende stoffen en van preparaten die ze be- vatten.
NL7512902A (nl) Werkwijze voor de bereiding van herbicide stoffen en van preparaten die ze bevatten.
NL7707684A (nl) Werkwijze voor de bereiding van hypolypemische stoffen en preparaten die ze bevatten.
NL7506008A (nl) Nieuwe pyridobenzodiazepionen en geneesmiddelen die ze bevatten.
NL7412629A (nl) Werkwijze ter bereiding van reuk- en smaakmid-
NL7514177A (nl) Werkwijze ter bereiding van nieuwe ergolinederi- vaten, alsmede werkwijze ter bereiding van farma- ceutische preparaten die deze ergolinederivaten bevatten.
NL7508706A (nl) Werkwijze ter bereiding van pyrazofurinederivaten, alsmede werkwijze ter bereiding van farmaceutische preparaten.
NL7502085A (nl) Werkwijze ter bereiding van verfpreparaten, die oxydatiekleurstoffen en difenylaminen bevatten.
NL7512847A (nl) Werkwijze voor de bereiding van contraceptieve stoffen en preparaten.
NL7506011A (nl) Werkwijze ter bereiding van nieuwe derivaten van benzodiazepinen en van farmaceutische preparaten, die deze nieuwe derivaten bevatten.
NL166015C (nl) Werkwijze voor de bereiding van prostaglandien-analoga en voor de bereiding van preparaten die ze bevatten.
NL7714205A (nl) Werkwijze ter bereiding van 5-fluoruracilderi- vaten en farmaceutische preparaten die deze derivaten bevatten.
NL7700899A (nl) Werkwijze voor de bereiding van coccidiostatica en van preparaten die ze bevatten.
NL7501886A (nl) Werkwijze voor de bereiding van nieuwe zoetstof- fen en van preparaten die ze bevatten.
NL7501878A (nl) Bloeddrukverlagende stoffen en preparaten die ze bevatten.

Legal Events

Date Code Title Description
BA A request for search or an international-type search has been filed
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
V4 Discontinued because of reaching the maximum lifetime of a patent